VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EDIT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EDITEditas Medicine, Inc.
$2.57$394M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEDITQuarterly Cash Flow

Editas Medicine, Inc. (EDIT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Editas Medicine, Inc. (EDIT) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

EDIT Cash Flow Statement

Quarterly statement

EDIT Cash Flow Statement

Editas Medicine, Inc. (EDIT) cash flow statement — 13-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-29.57M-23.06M-36.39M-30.84M-50.21M-47.8M-50.76M-52.59M-57.06M-49.87M-22.24M-35.46M-38.71M-35.77M-42.27M-48M-37.84M-49.23M-34.58M-40.78M
Operating CF Margin %-248.68%-814.59%-147.07%-408.9%-1403.35%-1026.17%-165.87%-86209.84%-11123.2%-4394.01%-37.04%-664.52%-1340.87%-363.09%-646.77%-114295.24%-594.86%-727.03%-277.34%-658.14%
Operating CF Growth %41.11%51.75%28.32%41.35%12%4.16%-128.25%-48.31%-47.41%-39.43%47.39%26.13%-2.29%27.34%-22.24%-17.7%2.85%0.51%13.76%25.58%
Net Income-18.23M-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M
Depreciation & Amortization416K483K805K721K1.83M1.92M1.38M1.6M1.42M1.41M1.47M1.51M1.54M1.54M1.58M1.6M1.6M1.56M1.51M1.19M
Stock-Based Compensation2.19M2.1M2.13M2.23M2.66M2.98M4.02M4.8M5.01M7.58M5.34M4.73M5.21M4.51M5.36M5.88M6.62M11.43M7.66M10.01M
Deferred Taxes0000000000-18.64M1.8M00000000
Other Non-Cash Items902K1.18M-489K2.34M3.15M5.78M1.33M-1.19M-2.29M-1.72M16.55M-3.04M-780K890K-498K-283K-177K234K325K422K
Working Capital Changes-14.85M-1.85M-33.21M-11.01M-4.62M17.61M-12.1M4.34M6.41M4.8M-8.09M4.56M-4.4M6.33M12.02M520K7.57M-11.94M-2.64M-13.33M
Change in Receivables-133K12.58M-7.05M-7.54M-78K15.76M-16.14M118K1K9.94M-7.76M-136K-2.04M4.9M-5.03M593K659K-1.1M-16K80K
Change in Inventory0000000000000000006.87M0
Change in Payables-58K1.73M-558K-3.56M1.26M-27K-7M-1.25M7.42M-1.46M-2.59M2.36M-699K-557K2.69M422K1.48M-229K1.84M-1.16M
Cash from Investing-29.8M64K58K39.57M42.65M56.39M30.96M83.98M51.95M-4.75M62.84M-102.82M12.98M23.27M-27.53M89.23M-4M56.37M-22.84M-39.66M
Capital Expenditures-106K-92K-60K-433K151K-114K-540K-2.92M-3.49M-1.87M-1.31M-239K-1.33M-1.84M-624K-614K-632K-2.25M-2.85M-2.34M
CapEx % of Revenue0.89%3.25%0.24%5.74%4.22%2.45%1.76%4788.52%681.09%164.85%2.18%4.48%46.17%18.68%9.55%1461.9%9.93%33.2%22.82%37.82%
Acquisitions-156K156K118K0000000-64.15M102.58M0-25.11M0018K046.49M0
Investments--------------------
Other Investing156K00000000064.15M-102.58M025.11M0000-46.49M0
Cash from Financing117.53M017.33M17.17M7.41M-1.44M55.51M0322K192K514K0117.53M0619K80K367K218K1.06M2.5M
Debt Issued (Net)0000-2.87M000000000000000
Equity Issued (Net)117.53M017.33M17.15M7.41M1.44M55.51M0322K192K514K0117.53M0619K80K367K218K1K2.5M
Dividends Paid00000000000000000000
Share Repurchases0000228K000000000000000
Other Financing00021K2.87M-2.87M0000000000001.06M0
Net Change in Cash58.17M-23M-19M25.9M-150K7.15M35.71M31.39M-4.79M-54.42M41.12M-138.28M91.8M-12.5M-69.18M41.3M-41.48M7.36M-56.37M-77.95M
Free Cash Flow-29.67M-23.15M-36.45M-31.28M-50.21M-47.91M-51.3M-55.51M-60.56M-51.74M-23.55M-35.7M-40.04M-37.61M-42.9M-48.62M-38.48M-51.48M-37.43M-43.13M
FCF Margin %-249.57%-817.84%-147.31%-414.64%-1403.35%-1028.62%-167.63%-90998.36%-11804.29%-4558.85%-39.21%-669%-1387.05%-381.77%-656.32%-115757.14%-604.79%-760.23%-300.16%-695.97%
FCF Growth %40.9%51.68%28.96%43.66%17.08%7.4%-117.87%-55.5%-51.22%-37.59%45.11%26.57%-4.07%26.94%-14.62%-12.73%7.64%-3.86%9.76%23.79%
FCF per Share-0.25-0.24-0.41-0.35-0.59-0.58-0.62-0.67-0.74-0.63-0.29-0.44-0.56-0.55-0.62-0.71-0.56-0.75-0.55-0.63
FCF Conversion (FCF/Net Income)1.62x0.92x6.47x1.23x0.94x0.63x1.12x0.85x0.84x0.81x1.18x0.79x0.96x0.73x0.70x0.86x0.71x0.97x0.83x1.04x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000